For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260113:nRSM5981Oa&default-theme=true
RNS Number : 5981O CVS Group plc 13 January 2026
13 January 2026
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 12 January 2026 it purchased the following number of its
ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 12/01/2026
Aggregate number of Ordinary Shares purchased: 29,888
Lowest price paid per share (GBp): 1,342.00
Highest price paid per share (GBp): 1,360.00
Volume weighted average price paid per share (GBp): 1,352.20
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,521,624 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,521,624 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,219,159 Ordinary Shares in aggregate at a weighted average price
of 1,234.87 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
68 1358 12/01/2026 08:02:32 1369399466395996 XLON
306 1360 12/01/2026 08:10:18 1369399466397284 XLON
87 1360 12/01/2026 08:10:18 1369399466397285 XLON
370 1358 12/01/2026 08:44:19 1369399466401242 XLON
196 1358 12/01/2026 08:44:19 1369399466401249 XLON
452 1358 12/01/2026 08:44:19 1369399466401250 XLON
455 1356 12/01/2026 08:47:17 1369399466401448 XLON
12 1354 12/01/2026 08:48:16 1369399466401503 XLON
150 1354 12/01/2026 08:49:13 1369399466401581 XLON
239 1354 12/01/2026 08:49:13 1369399466401582 XLON
14 1352 12/01/2026 08:53:58 1369399466401848 XLON
119 1352 12/01/2026 08:54:34 1369399466401892 XLON
24 1352 12/01/2026 08:54:34 1369399466401893 XLON
149 1352 12/01/2026 08:57:37 1369399466402256 XLON
176 1356 12/01/2026 09:08:09 1369399466403245 XLON
136 1354 12/01/2026 09:30:07 1369399466404909 XLON
76 1352 12/01/2026 09:49:51 1369399466406472 XLON
849 1350 12/01/2026 10:11:37 1369399466408022 XLON
905 1348 12/01/2026 10:11:37 1369399466408031 XLON
26 1346 12/01/2026 10:13:01 1369399466408124 XLON
800 1348 12/01/2026 10:19:48 1369399466408492 XLON
655 1344 12/01/2026 10:42:25 1369399466409552 XLON
94 1344 12/01/2026 10:42:25 1369399466409553 XLON
344 1346 12/01/2026 11:48:43 1369399466413724 XLON
177 1346 12/01/2026 11:48:43 1369399466413725 XLON
249 1346 12/01/2026 11:50:13 1369399466413810 XLON
257 1344 12/01/2026 11:55:30 1369399466414057 XLON
623 1344 12/01/2026 11:55:30 1369399466414058 XLON
186 1346 12/01/2026 12:31:20 1369399466415712 XLON
690 1346 12/01/2026 12:31:20 1369399466415713 XLON
21 1344 12/01/2026 12:33:47 1369399466415817 XLON
624 1344 12/01/2026 12:33:47 1369399466415818 XLON
302 1342 12/01/2026 12:41:45 1369399466416177 XLON
371 1342 12/01/2026 12:41:45 1369399466416178 XLON
41 1342 12/01/2026 12:41:45 1369399466416179 XLON
297 1342 12/01/2026 13:24:56 1369399466419452 XLON
423 1342 12/01/2026 13:24:56 1369399466419453 XLON
137 1346 12/01/2026 13:28:16 1369399466419689 XLON
553 1346 12/01/2026 13:28:16 1369399466419690 XLON
241 1346 12/01/2026 13:32:39 1369399466420001 XLON
840 1352 12/01/2026 14:05:29 1369399466422099 XLON
266 1352 12/01/2026 14:05:29 1369399466422100 XLON
98 1354 12/01/2026 14:07:51 1369399466422269 XLON
165 1352 12/01/2026 14:09:26 1369399466422399 XLON
569 1352 12/01/2026 14:09:26 1369399466422400 XLON
13 1354 12/01/2026 14:20:01 1369399466423216 XLON
162 1354 12/01/2026 14:20:01 1369399466423217 XLON
6 1354 12/01/2026 14:20:01 1369399466423218 XLON
180 1354 12/01/2026 14:20:01 1369399466423219 XLON
180 1354 12/01/2026 14:20:01 1369399466423220 XLON
180 1354 12/01/2026 14:20:01 1369399466423221 XLON
180 1354 12/01/2026 14:20:01 1369399466423222 XLON
122 1354 12/01/2026 14:20:01 1369399466423223 XLON
58 1354 12/01/2026 14:31:22 1369399466425146 XLON
227 1354 12/01/2026 14:31:22 1369399466425147 XLON
180 1354 12/01/2026 14:31:22 1369399466425152 XLON
971 1354 12/01/2026 14:31:22 1369399466425153 XLON
180 1354 12/01/2026 14:31:22 1369399466425154 XLON
32 1354 12/01/2026 14:31:22 1369399466425155 XLON
180 1354 12/01/2026 14:34:26 1369399466425739 XLON
75 1354 12/01/2026 14:38:35 1369399466426578 XLON
117 1354 12/01/2026 14:38:35 1369399466426579 XLON
180 1354 12/01/2026 14:42:33 1369399466427309 XLON
552 1354 12/01/2026 14:42:33 1369399466427311 XLON
180 1354 12/01/2026 14:42:33 1369399466427312 XLON
679 1354 12/01/2026 14:42:33 1369399466427313 XLON
180 1354 12/01/2026 14:42:33 1369399466427314 XLON
180 1354 12/01/2026 14:42:33 1369399466427315 XLON
180 1354 12/01/2026 14:42:33 1369399466427316 XLON
169 1354 12/01/2026 14:42:33 1369399466427317 XLON
11 1354 12/01/2026 14:42:33 1369399466427318 XLON
3 1354 12/01/2026 14:42:33 1369399466427319 XLON
180 1354 12/01/2026 14:42:33 1369399466427320 XLON
159 1354 12/01/2026 14:42:33 1369399466427321 XLON
21 1354 12/01/2026 14:42:33 1369399466427322 XLON
21 1354 12/01/2026 14:42:33 1369399466427323 XLON
159 1354 12/01/2026 14:42:33 1369399466427324 XLON
21 1354 12/01/2026 14:42:33 1369399466427325 XLON
53 1354 12/01/2026 14:42:33 1369399466427326 XLON
48 1352 12/01/2026 14:42:36 1369399466427338 XLON
43 1352 12/01/2026 14:42:37 1369399466427339 XLON
77 1354 12/01/2026 14:48:27 1369399466428211 XLON
277 1354 12/01/2026 14:48:27 1369399466428214 XLON
96 1352 12/01/2026 14:49:00 1369399466428282 XLON
18 1352 12/01/2026 15:11:15 1369399466431688 XLON
484 1352 12/01/2026 15:11:15 1369399466431689 XLON
138 1352 12/01/2026 15:11:20 1369399466431705 XLON
180 1354 12/01/2026 15:39:21 1369399466435022 XLON
47 1354 12/01/2026 15:39:21 1369399466435023 XLON
180 1354 12/01/2026 15:39:22 1369399466435024 XLON
720 1354 12/01/2026 15:39:22 1369399466435025 XLON
170 1360 12/01/2026 15:54:28 1369399466437275 XLON
134 1358 12/01/2026 15:55:28 1369399466437457 XLON
1201 1358 12/01/2026 15:55:28 1369399466437458 XLON
1307 1358 12/01/2026 15:57:13 1369399466437771 XLON
104 1354 12/01/2026 15:57:13 1369399466437774 XLON
480 1356 12/01/2026 16:03:26 1369399466438720 XLON
6 1356 12/01/2026 16:03:26 1369399466438721 XLON
1299 1356 12/01/2026 16:09:11 1369399466439863 XLON
180 1356 12/01/2026 16:10:22 1369399466440027 XLON
180 1356 12/01/2026 16:10:22 1369399466440028 XLON
180 1356 12/01/2026 16:10:22 1369399466440029 XLON
44 1356 12/01/2026 16:10:22 1369399466440030 XLON
43 1356 12/01/2026 16:10:22 1369399466440031 XLON
93 1356 12/01/2026 16:10:22 1369399466440032 XLON
87 1356 12/01/2026 16:10:22 1369399466440033 XLON
180 1356 12/01/2026 16:10:22 1369399466440034 XLON
180 1356 12/01/2026 16:10:22 1369399466440035 XLON
180 1356 12/01/2026 16:10:22 1369399466440036 XLON
180 1356 12/01/2026 16:10:22 1369399466440037 XLON
180 1356 12/01/2026 16:10:22 1369399466440038 XLON
55 1356 12/01/2026 16:10:22 1369399466440039 XLON
831 1354 12/01/2026 16:10:22 1369399466440043 XLON
198 1354 12/01/2026 16:17:57 1369399466441515 XLON
83 1354 12/01/2026 16:17:57 1369399466441516 XLON
202 1354 12/01/2026 16:29:05 1369399466444080 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSGPUWCGUPQPUP
Copyright 2019 Regulatory News Service, all rights reserved